-
BURDEN OF PREVENTABLE MEDICATION ERRORS IN SPAIN: CLINICAL AND ECONOMIC IMPACT, AND THE POTENTIAL OF HEALTH TECHNOLOGIES
Aug 11, 2026, 17:15 PM -
VARIATION IN CONCEPTUAL AND OPERATIONAL DEFINITIONS OF DEPRESSION IN REAL-WORLD RESEARCH
Aug 11, 2026, 17:15 PM -
REVERSING FINLAND'S LONG-TERM DECLINE IN INDUSTRY-SPONSORED CLINICAL TRIALS COULD ADD OVER €1 BILLION IN SOCIETAL VALUE BY 2030
Aug 11, 2026, 17:15 PM -
DECODING CLINICAL HEURISTICS IN EARLY ALZHEIMER'S DISEASE: NEUROLOGISTS' PREFERENCES AND TRADE-OFFS IN AMYLOID-TARGETING THERAPY INITIATION
Aug 11, 2026, 17:15 PM -
ESMO-MCBS: DO CURRENT CRITERIA UNDERVALUE CLINICAL BENEFIT IN POOR-PROGNOSIS POPULATIONS
Aug 11, 2026, 17:15 PM -
HIGH BURDEN OF DEPRESSION AND ANXIETY IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM GERMAN CLAIMS AND CLINICAL DATA
Aug 11, 2026, 17:15 PM -
COMPARATIVE EFFECTIVENESS OF GABAPENTIN ALONE AND MEMANTINE WITH GABAPENTIN IN DIABETIC NEUROPATHY PATIENTS: EVIDENCE TO SUPPORT CLINICAL DECISION-MAKING
Aug 11, 2026, 17:15 PM -
MMR-MSI TESTING PATTERNS IN A REAL-WORLD CANADIAN SETTING: INSIGHTS FROM AN AI-ENABLED ANALYSIS
Aug 11, 2026, 17:15 PM -
LINKING PHARMACY CLAIMS AND EHR-DERIVED ANTHROPOMETRICS TO EVALUATE REAL-WORLD GLP-1 OUTCOMES IN OBESITY LEVERAGING NORSTELLALINQ EHR AND VITALS DATA
Aug 11, 2026, 17:15 PM -
MODELLED ESTIMATION OF DIRECT HEALTHCARE COSTS ATTRIBUTABLE TO OBESITY-RELATED COMORBIDITIES IN THE ENTITY OF REPUBLIKA SRPSKA
Aug 11, 2026, 17:15 PM -
UPDATED COST-EFFECTIVENESS ANALYSIS OF EVOLOCUMAB IN PATIENTS WITH CLINICALLY EVIDENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Aug 11, 2026, 17:15 PM -
REAL-WORLD USE OF GLP-1 RECEPTOR AGONISTS IN PORTUGUESE COMMUNITY PHARMACIES: THERAPEUTIC INDICATIONS, REIMBURSEMENT, AND ACCESS TO TREATMENT
Aug 11, 2026, 17:15 PM -
A GENERAL FRAMEWORK FOR IPD META-ANALYSIS OF COMPETING RISKS DATA WITH FLEXIBLE PARAMETRIC SURVIVAL MODELS: ESTIMATION, PREDICTION AND SOFTWARE
Aug 11, 2026, 17:15 PM -
NET-PRICE INFORMATION ASYMMETRY IN REIMBURSEMENT NEGOTIATION: AN ECONOMICALLY JUSTIFIABLE PRICE REFERENCE FRAMEWORK FOR ENTRANT THERAPIES
Aug 11, 2026, 17:15 PM -
BURDEN OF ILLNESS OF METACHROMATIC LEUKODYSTROPHY - AN AI ASSISTED TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:15 PM -
STATE TRANSITION OR PARTITIONED SURVIVAL MODEL? MODEL SELECTION FRAMEWORKS FOR EARLY-STAGE ONCOLOGY
Aug 11, 2026, 17:15 PM -
HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE IN CHINA: A MIXED-METHODS STUDY
Aug 11, 2026, 17:15 PM -
CAN A LARGE LANGUAGE MODEL QUALITY CONTROL A HEALTH-ECONOMIC MODEL? RELIABILITY AND FAILURE MODES OF A LARGE LANGUAGE MODEL AS A QUALITY-CONTROL REVIEWER OF HEALTH-ECONOMIC MODELS
Aug 11, 2026, 17:15 PM -
COST OF FALLS AVERTED AND BURDEN PREVENTED BY CONVERSATIONAL VOICE AI FALL-RISK SCREENING IN OLDER ADULTS: A COST-CONSEQUENCE ANALYSIS
Aug 11, 2026, 17:15 PM -
MEDICATION ADHERENCE, TREATMENT SATISFACTION IN PATIENTS WITH MOOD DISORDERS AT A SAUDI TERTIARY CARE HOSPITAL: A CROSS-SECTIONAL STUDY
Aug 11, 2026, 17:15 PM
